Nurse Practitioner · New York, NY
NPI
1306048665
Since 2007
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1425 Madison Ave
New York, NY, 10029
Phone (212) 659-8086
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
250 services
Medicare patients, 2024
60
Average age 68
Drug cost, 2024
$3.4M
13,257 prescriptions
Company payments, 2025
$291
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rafael Khaim was code 99213 (office e&m - established), 190 times for 52 patients. In total Rafael Khaim billed 250 services in 16 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 190 | 52 | $62.55 | $12K |
| 36415 Venipuncture Blood Collection | Office | 16 | 15 | $8.65 | $138 |
| 99203 Office E&M - New | Office | 14 | 14 | $72.68 | $1,018 |
By year: 2022 $14K for 231 services; 2023 $15K for 234 services; 2024 $15K for 250 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 16 | 15 | $8.65 | $138 |
Medicare prescription drug claims, 2024
In 2024, the drug Rafael Khaim prescribed most often to Medicare patients was Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim), with 1,682 prescriptions and refills. In total Rafael Khaim wrote 13,257 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 1,682 | 2,609 | 378 | $8,615 |
| Famotidine Generic | 935 | 1,595 | 272 | $3,921 |
| Valganciclovir Hcl Generic | 681 | 922 | 210 | $133K |
| Tamsulosin Hcl Generic | 641 | 1,204 | 188 | $6,905 |
| Nifedipine Er Nifedipine | 583 | 1,044 | 172 | $11K |
| Prednisone Generic | 580 | 1,039 | 176 | $4,665 |
| Atorvastatin Calcium Generic | 510 | 1,072 | 169 | $3,975 |
| Tacrolimus Generic | 502 | 817 | 125 | $117K |
| Pantoprazole Sodium Generic | 425 | 776 | 131 | $4,152 |
| Cinacalcet Hcl Generic | 418 | 777 | 106 | $195K |
| Mycophenolate Mofetil Generic | 316 | 566 | 114 | $38K |
| Metoprolol Tartrate Generic | 303 | 536 | 87 | $1,489 |
| Carvedilol Generic | 297 | 478 | 102 | $1,953 |
| Amlodipine Besylate Generic | 257 | 537 | 95 | $1,044 |
| Lokelma Sodium Zirconium Cyclosilicate | 224 | 241 | 69 | $195K |
Brand drugs: 1,467 claims; generic drugs: 11,198 claims; opioid claims: 124.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rafael Khaim $291 ($291 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.